Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer [NA]

View source ↗

Summary

A recruiting clinical trial is evaluating partial tumor irradiation in combination with immunotherapy for unresectable lung cancer, including lung adenocarcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Karl Landsteiner University of Health Sciences | Conditions: Lung Adenocarcinoma, Bulky Tumors | NA | Status: RECRUITING